Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Laryngeal papillomatosis

Treatment of bladder, cervical, renal carcinoma, chronic myelocytic leukemia, laryngeal papillomatosis, multiple myeloma, mycosis fungoides... [Pg.633]

In refractory condylomata acuminata (genital warts), intralesional injection of various IFNs is associated with complete clearance in 36-62% of patients, but other treatments are preferred. Relapse occurs in 20-30% of patients. Verruca vulgaris may respond to intralesional IFN-CC. Intramuscular or subcutaneous administration is associated with regression in wart size but greater toxicity. Systemic IFN may provide benefit in recurrent juvenile laryngeal papillomatosis and laryngeal disease in older patients. [Pg.833]

Phosphodiesterase, which degrades the terminal nucleotides of tRNA and thus inhibiting peptide elongation. Systemic INF-a is currently approved in US for the treatment of chronic HBV and HBC infections. It is also clinically approved for the treatment of AIDS-associated Kaposi s sarcoma and laryngeal papillomatosis. [Pg.489]

Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-GriimingCT D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM (2000) Placebo-ctnitrolled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78(2) 123—129 Aubom K, Abramson A, Bradlow HL, Sepkovic D, Mullooly V (1998) Estrogen metabolism and laryngeal papillomatosis a pilot study on dietary preventimi. Anticancer Res 18 4569 573... [Pg.45]

See other pages where Laryngeal papillomatosis is mentioned: [Pg.226]    [Pg.229]    [Pg.211]    [Pg.213]    [Pg.704]    [Pg.74]    [Pg.226]    [Pg.229]    [Pg.211]    [Pg.213]    [Pg.704]    [Pg.74]    [Pg.61]   
See also in sourсe #XX -- [ Pg.213 ]



SEARCH



Laryngitis

© 2024 chempedia.info